|
 |
| CASE REPORT |
|
|
|
| Year : 2016 | Volume
: 31
| Issue : 4 | Page : 289-291 |
|
|
Laryngeal squamous cell cancer with late presentation of isolated liver metastasis on fluorodeoxyglucose positron emission tomography-computed tomography
Sabire Yilmaz Aksoy1, Betül Vatankulu2, Metin Halac2, Kerim Sönmezoglu2
1 Department of Nuclear Medicine, Ankara Ataturk Training and Research Hospital, Ankara, Turkey
2 Department of Nuclear Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
| Date of Web Publication | 19-Sep-2016 |
Correspondence Address:
Sabire Yilmaz Aksoy
Department of Nuclear Medicine, Ankara Ataturk Training and Research Hospital, Ankara
Turkey
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0972-3919.187463
 Abstract | | |
Laryngeal cancer is the second most common type of head and neck malignancy, representing approximately 45% of all head and neck cancers. Hematogenous spread to the liver rarely occurs without evidence of pulmonary and bone disease. We report a patient who had been treated 7 years earlier for laryngeal squamous cell cancer and who had isolated liver metastasis on fluorodeoxy D-glucose positron emission tomography-computed tomography.
Keywords: Fluorodeoxy D-glucose positron emission tomography-computed tomography, laryngeal cancer, liver metastasis
How to cite this article:
Aksoy SY, Vatankulu B, Halac M, Sönmezoglu K. Laryngeal squamous cell cancer with late presentation of isolated liver metastasis on fluorodeoxyglucose positron emission tomography-computed tomography. Indian J Nucl Med 2016;31:289-91 |
How to cite this URL:
Aksoy SY, Vatankulu B, Halac M, Sönmezoglu K. Laryngeal squamous cell cancer with late presentation of isolated liver metastasis on fluorodeoxyglucose positron emission tomography-computed tomography. Indian J Nucl Med [serial online] 2016 [cited 2022 Aug 16];31:289-91. Available from: https://www.ijnm.in/text.asp?2016/31/4/289/187463 |
| Introduction | |  |
Laryngeal cancer is the second most common type of head and neck malignancy, representing approximately 45% of all head and neck cancers. The majority of larynx cancer was squamous cell cancer (SCC), and they can involve the supraglottis (30%), glottis (65%), and subglottis (5%).[1] These tumors spread regionally by the lymphatic way and distally by the hematogenous way, except for glottic cancers. Tumor volume and biological aggressiveness affect the regional and distant metastases. Regional metastases usually tend to arise ipsilateral to primary tumor. Supraglottic larynx cancers most frequently metastasize to the upper jugular lymph nodes.[1]
18 F-fluorodeoxy-D-glucose positron emission tomography-computed tomography (18 F-FDG-PET-CT) has been effectively used in evaluation of head and neck squamous cell carcinomas and has been shown to be useful in various clinical settings, ranging from pretreatment staging to radiotherapy planning, treatment response assessment, and posttherapy follow-up. Locoregional or distant recurrence can occur in head and neck cancers despite initial aggressive treatment, especially within the 1st year. Early detection of locoregional disease may improve survival by increasing the effectiveness of salvage therapy. However, the real advantage of early detection of distant metastases in asymptomatic patients is still unclear.[2] PET-CT imaging is superior to physical examination and conventional imaging in detection of locoregional recurrence, as well as distant lesions and metachronous primary tumors.
The incidence of distant metastasis is relatively low in head and neck squamous cell carcinoma in comparison to other malignancies but remains a major determinant of prognosis. Therefore, detection of distant metastases is an important factor in clinical decision-making. Distant metastasis is seen in 11–26% of patients with head and neck cancer.[3],[4] However, one study reported that distant metastasis occurs in only 5% of the patients, for whom initial treatment had achieved locoregional control.[5] In this case report, we presented a patient with laryngeal SCC who develop isolated liver metastasis 7 years after diagnosis.
| Case Report | | |
A 51-year-old male patient with laryngeal cancer had a history of total laryngectomy + bilateral lymph node dissection operation 7 years ago. The patient had also received adjuvant chemotherapy and local radiation therapy. He had no complaint until the last 2 weeks; however, then, he reported right upper abdominal pain. On physical examination, tenderness in liver area and hepatomegaly were found. Abdominal ultrasound showed a gross mass lesion in the liver, and the patient referred to the nuclear medicine department for FDG-PET/CT scan to restage the disease.
FDG-PET/CT demonstrated that there was a gross mass lesion replacing the right hepatic lobe and extending to medial segment of the left lobe which had very intense FDG accumulation (maximum standardized uptake value: 32, 7), with hypometabolic necrotic area. In addition, there was increased FDG uptake at the celiac lymph node measuring approximately 1 cm in diameter in the upper abdomen [Figure 1], arrow]. On the other hand, there was no pathological tracer uptake at the laryngeal region and cervical-mediastinal lymphatic stations [Figure 1]. The Tru-cut biopsy of the liver mass confirmed poorly differentiated squamous cell metastasis. Upon this, the patient received chemotherapy (cisplatin, docetaxel, and zometa) for 6 months. Posttreatment CT imaging demonstrated progression of liver metastasis and the patient died 15 days after CT imaging. | Figure 1: Axial positron emission tomography (a), computed tomography (b), positron emission tomography-computed tomography fusion (c), and maximum intensity projection (d) images of a 51-year-old male patient with laryngeal cancer. Fluorodeoxy D-glucose positron emission tomography-computed tomography demonstrated that there was a gross mass lesion replacing the right hepatic lobe and extending to medial segment of left lobe which had very intense fluorodeoxy D-glucose accumulation (maximum standardized uptake value: 32, 7) with hypometabolic necrotic area and celiac lymph node measuring approximately 1 cm in diameter with increased fluorodeoxy D-glucose uptake (arrow)
Click here to view |
Here, we reported a case of laryngeal SCC with late liver-only metastasis on FDG-PET/CT.
| Discussion | | |
In head and neck cancer, the majority of distant metastases appear within 2 years of diagnosis which is mostly to the lung (45–85%), followed by bones (10–30%) and liver (5–22%).[3],[4],[5] Our patient presented with isolated liver metastasis 7 years after complete resection of tumor although hematogenous spread to liver rarely occurs without evidence of pulmonary and bone disease. There were also some reports of soft-tissue metastases from laryngeal cancer including gluteus maximus and scapular muscles. Another report describes supraglottic larynx cancer which involves all five distal phalanges of the left hand with simultaneous metastases to lung and liver.[6]
Several posttreatment studies found that FDG-PET had a similar accuracy for the detection of locoregional and distant recurrence in head and neck cancer. Sensitivities ranged from 92% to 100%, specificities from 64% to 100%, positive predictive values from 64% to 100%, negative predictive values from 92% to 100%, and overall accuracy from 88% to 91% in these studies.[7],[8] The performance of PET/CT for the detection of distant metastases in patients with laryngeal cancer was even better, with an accuracy of 100%, probably because posttreatment changes are not seen outside the cervical region.
The goal of the treatment is definitive cure for larynx cancer. The commonly used treatment modalities are both surgery and radiotherapy.[1] Several investigators have reported using conformal radiation therapy or hepatic arterial infusion chemotherapy [9] for patients with isolated SCC metastasis to the liver. The benefit of liver surgery in hepatic-only metastasis from head and neck cancer is not clear. Although screening for metastasis is believed to be senseless during follow-up, 5-year survival of 15–20% can be expected in patients with isolated liver metastasis by surgery.[10] Hence, early and accurate detection of metastases may play an important role for patient survival. Although liver function tests may detect abnormality, elevation in liver enzymes has low sensitivity or specificity for liver involvement. A whole-body FDG-PET/CT scanning is a useful method to restage the disease. In conclusion, hematogenous spread to the liver rarely occurs without evidence of pulmonary and bone disease. Although most of the metastases are seen within the 1st year, our patient presented with isolated liver metastasis 7 years after laryngeal cancer diagnosis. We used PET/CT to define this as an isolated lesion. The systematic use of PET/CT of the usual follow-up could be proposed, but it should be noted that cost-effectiveness and survival analysis is needed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | | |
| 1. | Licitra L, Bernier J, Grandi C, Locati L, Merlano M, Gatta G, et al. Cancer of the larynx. Crit Rev Oncol Hematol 2003;47:65-80.  [ PUBMED] |
| 2. | Mak D, Corry J, Lau E, Rischin D, Hicks RJ. Role of FDG-PET/CT in staging and follow-up of head and neck squamous cell carcinoma. Q J Nucl Med Mol Imaging 2011;55:487-99. |
| 3. | Alvi A, Johnson JT. Development of distant metastasis after treatment of advanced-stage head and neck cancer. Head Neck 1997;19:500-5. [ PUBMED] |
| 4. | de Bree R, Deurloo EE, Snow GB, Leemans CR. Screening for distant metastases in patients with head and neck cancer. Laryngoscope 2000;110(3 Pt 1):397-401. |
| 5. | León X, Quer M, Orús C, del Prado Venegas M, López M. Distant metastases in head and neck cancer patients who achieved loco-regional control. Head Neck 2000;22:680-6. |
| 6. | Kumar N, Bera A, Kumar R, Ghoshal S, Angurana SL, Srinivasan R. Squamous cell carcinoma of supraglottic larynx with metastasis to all five distal phalanges of left hand. Indian J Dermatol 2011;56:578-80. [ PUBMED]  |
| 7. | Wong RJ, Lin DT, Schöder H, Patel SG, Gonen M, Wolden S, et al. Diagnostic and prognostic value of [(18) F] fluorodeoxyglucose positron emission tomography for recurrent head and neck squamous cell carcinoma. J Clin Oncol 2002;20:4199-208. |
| 8. | Kunkel M, Förster GJ, Reichert TE, Jeong JH, Benz P, Bartenstein P, et al. Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: Implications for prognosis and patient management. Cancer 2003;98:2257-65. |
| 9. | Nakajima Y, Nagai K, Kawano T, Inoue H, Nara S, Kumagai Y, et al. Therapeutic strategy for postoperative liver metastasis from esophageal squamous cell carcinoma; clinical efficacy of and problem with hepatic arterial infusion chemotherapy. Hepatogastroenterology 2001;48:1652-5. [ PUBMED] |
| 10. | Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D. Improving resectability of hepatic colorectal metastases: Expert consensus statement. Ann Surg Oncol 2006;13:1271-80. [ PUBMED] |
[Figure 1]
|
